Continuous glucose monitoring (CGM) represents a significant advance for the treatment of patients with diabetes mellitus. 1 Usage of CGM enables an increased understanding of the effects that various influences of daily life have on changes in glucose levels, for example, diet, insulin, and physical exercise.
. This training and treatment program is available in a version for adults, one adopted for parents of mainly younger children and one for adolescents with type 1 diabetes (see example in Figure 2 ). All 3 versions include detailed curricula adapted to the age-specific needs and challenges in everyday life with type 1 diabetes. The materials and didactic tools support diabetes centers with less experience with CGM to become capable of providing a comprehensive CGM training. If the program can be successfully evaluated by an appropriately designed and performed clinical study, then reimbursement can be achieved by the payers in Germany. This would be an important step forward in achieving more widespread acceptance and use of CGM systems.
Structure of SPECTRUM
To make the best use of CGM, the patients need to have a good understanding of a variety of physiological and technical aspects. 2 The most important aims of the training and treatment program are The adult version of SPECTRUM consists of an introductory module, followed by 6 training modules each about 90 minutes long (Table 1 ). The pediatric versions (one for the adolescents and one for the parents with mainly younger children) consist of an introductory module and 5 training modules (Table 2) . No content was left out for the pediatric versions. The different number of training sessions is due to the different setting with smaller group size in the pediatric versions and more outpatient visits at follow-up.
The number of patients that should attend the training modules for adults is intended to be 2 to 6 patients. For parents of very young children the group size should be small, or individual training sessions should be offered.
For patients that are not hospitalized a time frame of about 8 weeks should be planned for participation in the whole training program (a time range between 4 and 12 weeks can be considered, see Table 3 ). For children and teenagers, variations in the time frame are optional, in particular when used in the context of inpatient care or day clinics.
Performance of SPECTRUM
Patients who are interested in using a CGM system should first take part in the introductory module (Module 0). This module can be employed in different settings, for example, as part of an introductory meeting, or as part of a training session for patients to be trained in intensified insulin therapy (IIT) or insulin pump therapy. This module is freely available on the internet (on the homepages of the AGDT and AGPD). Reimbursement of this introductory session will not be possible in Germany, therefore this session is defined as "module 0." After participation of this initial module, those patients who are seriously interested in CGM should speak to their diabetes team for further approach. When a patient or the parents of a child decide that they want to use a CGM system and the system is available to them, then the actual training program can start (Table 1: adult version, Table 2 : pediatric versions of SPECTRUM) In this example taken from the adult version of SPECTRUM the patients should note their personal expectations connected with CGM use on a special card. This card will be stored until the end of SPECTRUM by the diabetes team and then discussed again. (d) As strict product neutrality is crucial for reimbursement of a patient educational program in Germany, we developed a neutral CGM display. This example is taken from the adolescents' version of SPECTRUM and patients are asked to discuss the correct reaction to a low alarm. (e) This example is taken from the adult version of SPECTRUM and shows how patients are trained for interpreting their CGM display by discussing small "real" cases. Patients are asked in a very structured way to describe what they see on the display, which causes may underlie, and what the patient should do now in this situation. The next slides show the same case a few hours later (not shown). (f) The patients are suggested a structured way of interpreting CGM data (retrospective analysis) in 4 steps: detect recurrent hypoglycemia and assess glucose levels during nighttime and before and after meals. This algorithm is practiced with own CGM data during the training sessions. Module 0 Introduction Module 0 offers the participant a solid knowledge of the basic principles of CGM so that they can make an informed decision whether or not to use a CGM system. An explanation is given of how a CGM system works, the advantages and disadvantages are discussed, an overview of available CGM systems is given, and the process for reimbursement of costs is explained. Module 0 can be used in a variety of settings (large or small groups or individual consultations).
Module 1
Basic principles of CGM The participants are told in detail about how CGM systems work. The characteristics of tissue glucose measurements are discussed comprehensively. Basic knowledge with respect to the precision of the CGM system, the alarm settings, and the calibration also is presented. Module 2 CGM start Participants start working with their CGM system; they insert the first sensor and receive hints on how to make it safely through the first days of CGM use. Together with the trainer, sensible alarm settings are programmed and the calibration procedure is discussed. Module 3 CGM display and alarms At the beginning of this module the participants exchange their first experiences with using the system in daily life. They should also reflect upon their own experiences with the system. The participants learn to analyze and correctly interpret the data displayed by the CGM system so that they can make informed decisions on the appropriate therapy.
Module 4 CGM analysis 1
The main aim of module 4 is to learn the methodology needed to evaluate the stored data. An overview analysis of the glucose trace over several days is carried out. An in-depth analysis of the individual days will then be performed. Finally, conclusions and therapy targets, which should be achieved by the next module, will be defined by the participants themselves. Module 5 CGM analysis 2 The prime objective of module 5 is to practice the learnt methodology for the evaluation of CGM data. Again all of the data of each participant are evaluated (but not rated). By practicing together, the participants can gain confidence on how to deal with the "flood" of data and possible uncertainties can be reduced. Module 6 CGM advanced training Problems that have occurred when changing the sensor (eg, where they should be applied, adhesion problems, skin reactions) are discussed retrospectively. The participants gather more information, for example CGM in conjunction with physical exercise, swimming, use in the sauna, on holiday or in hospital.
• To address typical pediatric challenges, several psychological elements were included in the pediatric modules with worksheets on realistic expectations and targets for adolescents and parents and specific pediatric practical aspects, like CGM in nursery and school, child-appropriate explanation, CGM in challenging social situations, alerts at night and day, skin protection, and pain reduction at sensor insertion.
Materials Used by SPECTRUM
This training and treatment program consists of specific sets of slides for adults (introductory session + 6 training modules) and for parents with younger children and adolescents (introductory session + 5 training modules for each version). The slides are digitally available on a memory stick and in 2 different measurement units (mg/dl or mmol/l). In addition, a SPECTRUM folder is available that contains the detailed curricula in printed form for each of the 3 versions. The memory stick also contains a range of worksheets and checklists for the patients that can be printed for each participant in their required measurement unit. SPECTRUM was published in German in January 2016 by Kirchheim Verlag, Mainz. Translations into other languages are planned.
Summary
SPECTRUM, a training and treatment program for CGM, has been developed for patients with diabetes to make the best use of CGM in daily life. To our knowledge SPECTRUM is the first comprehensive and product neutral CGM training and treatment program for patients of all age groups. 
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